Serina Therapeutics share price logo

Serina Therapeutics

AMEX: SER

$1.96

+0.01

(+0.51%)

as on

Serina Therapeutics Stock Performance

as on October 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.95
    $2.10
    downward going graph

    0.51%

    Downside

    7.14%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.22
    $5.83
    downward going graph

    37.76%

    Downside

    197.45%

    Upside

    downward going graph

Serina Therapeutics share price movements today

Previous Close
$1.95
Open
$1.98
Volume
101.5K
Market Cap
$49.5M
Day's Low - High
$1.95 - $2.10
52 Week Low - High
$1.22 - $5.83

Serina Therapeutics Historical Returns

1 Month Return
-27.14 %
3 Month Return
+ 3.16 %
1 Year Return
-62.56 %
3 Year Return
0 %
5 Year Return
0 %

Serina Therapeutics Stock Fundamentals & Key Indicators

Check Serina Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$49.5M

EPS (TTM)

-1.88

Dividend Yield

0.00%

PE Ratio (TTM)

-1.09

Industry PE ratio

-2.27

PEG Ratio

0.02

Return On Equity TTM

-222.42%

Serina Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Serina Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$49.5MNA-1.090.00%0.00%
StrongBuy$44.1B609.62%-23.340.00%0.00%
Neutral$75.4B-44.29%-24.08-12.57%0.00%
StrongBuy$132.5B180.98%30.1986.04%0.00%
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for Serina Therapeutics Stock including INR - Dollar returns

The Serina Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Serina Therapeutics investment value today

Current value as on today

₹40,632

Returns

-₹59,368

(-59.37%)

Returns from Serina Therapeutics Stock

-₹62,560 (-62.56%)

Dollar Impact

₹3,192 (+3.19%)

Analyst Recommendation on Serina Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Serina Therapeutics. Average target price of $9.5

Indian Investors' Interest in Serina Therapeutics Stock

Search interest for Serina Therapeutics Stock has increased by 76% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:76% versus previous 30 day period

Serina Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
-
0
0
-
0
-
-
-
-
Gross Profit
0
-
-2
-2
-
0
-3
-3
0
-
Operating Income
-2
-3
-5
-5
-5
-5
-6
-6
-6
-6
EBITDA
-14
5
1
-2
-4
-6
-4
-3
-7
-7
Interest Expense
0
0
0
0
-
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-15
5
1
-2
-4
-6
-4
-3
-6
-6
Income Tax Expense
-
-
-
-
-
-
-
0
0
-
Net Income
-15
5
1
-2
-4
-6
-4
-3
-6
-6
Net Profit Margin
-400.00%
0.00%
100.00%
100.00%
0.00%
87.69%
0.00%
0.00%
0.00%
0.00%

Serina Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Mar 2021
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
1
1
0
3
0
3
0
-
Gross Profit
0
0
0
-1
0
0
3
0
-
Operating Income
-8
-10
-12
-10
-1
-2
-3
-17
-24
EBITDA
-7
-7
-11
-8
-1
-2
5
-10
-18
Interest Expense
0
-
-
0
0
0
0
0
0
Depreciation
0
0
0
1
0
0
0
0
0
Income Before Tax
-6
-7
-12
-10
-1
-2
5
-11
-19
Income Tax Expense
-
-
0
-
-
-
-
-
0
Net Income
-6
-7
-12
-10
-1
-2
5
-11
-19
Net Profit Margin
51.21%
39.76%
42.22%
-2272.22%
100.00%
100.00%
97.15%
-246.43%
0.00%

Serina Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
5
1
-2
-4
-6
-4
-3
-6
-6
Operating Cash Flow
-1
-8
-2
-4
-4
-3
-3
-6
-4
-6
Investing Cash Flow
0
-
0
0
-
0
0
-
0
0
Financing Cash Flow
2
5
0
5
4
5
6
0
26
5
Change in Cash
1
-2
-2
0
0
1
2
-5
21
-1

Serina Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Mar 2021
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-7
-12
-10
-1
-2
5
-11
-19
Operating Cash Flow
-6
-7
-10
-7
-2
-2
-2
-17
-17
Investing Cash Flow
0
1
0
0
0
0
0
0
0
Financing Cash Flow
13
6
6
5
1
1
10
13
17
Change in Cash
7
0
-4
-1
0
0
7
-3
0

Global Institutional Holdings in Serina Therapeutics

Check out the Institutions with significant holdings in Serina Therapeutics.

Funds
Holdings
Vanguard
0.70%
VANGUARD INDEX FUNDS
0.63%
Fidelity Concord Street Trust
0.14%
Bridgeway Funds, Inc.
0.01%
Bridgeway
0.01%

Insights on Serina Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -6.89M → -6.35M (in $), with an average increase of 8.5% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -14.0K → 130.0K (in $), with an average increase of 110.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 629.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SER stock has moved down by -27.1%

About Serina Therapeutics

Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
OrganisationSerina Therapeutics
Headquarters601 Genome Way, Huntsville, AL, 35806, US
IndustryBiotechnology
CEOSteven A. Ledger

Key Management of Serina Therapeutics

Name

Title

Dr. Srini Tenjarla Ph.D.

Chief Technical Operations Officer

Dr. Randall W. Moreadith M.D., Ph.D.

Chief Development Officer

Mr. Gregory S. Curhan

Chief Financial Officer

Dr. Joshua Thomas Ph.D.

Head of Chemistry

Dr. Balkrishan Gill Ph.D.

Executive Co-Chairman of the Board

Mr. Steven A. Ledger

CEO & Director

Dr. J. Milton Harris Ph.D.

Co-Founder, Director Emeritus & Chair of Scientific Advisory Board

FAQs

What is Serina Therapeutics share price today?

Serina Therapeutics share price today is $1.96 as on at the close of the market. Serina Therapeutics share today touched a day high of $2.10 and a low of $1.95.

What is the 52 week high and 52 week low for Serina Therapeutics share?

Serina Therapeutics share touched a 52 week high of $5.83 on and a 52 week low of $1.22 on . Serina Therapeutics stock price today i.e. is closed at $1.96,which is 66.38% down from its 52 week high and 60.66% up from its 52 week low.

What is Serina Therapeutics's market capitalisation today?

Serina Therapeutics market capitalisation is $0.00T as on .

How to invest in Serina Therapeutics Stock (SER) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Serina Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Serina Therapeutics Stock (SER) from India?

Indian investors can start investing in Serina Therapeutics (SER) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Serina Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Serina Therapeutics share’s latest price of $1.96 as on October 3, 2026 at 8:45 am IST, you will get 5.1020 shares of Serina Therapeutics. Learn more about fractional shares .